Former Suntory Holdings chairman Goshi Ninagawa will not be prosecuted following allegations that he smuggled illegal supplements containing cannabis-derived ingredients [1].
The decision concludes a legal process involving one of Japan's most prominent business figures and highlights the strict enforcement of pharmaceutical and narcotics laws regarding imports.
The Fukuoka District Public Prosecutor's Office issued the decision not to prosecute on May 22, 2026 [2]. This move follows a document indictment that occurred in April 2026 [3].
Ninagawa, 67, was under investigation for the import of supplements that contained substances derived from cannabis [3]. Under Japanese law, the importation of such ingredients without proper authorization is a criminal offense.
Prosecutors did not provide detailed reasoning for the decision to drop the charges [2]. The case had been handled by the Fukuoka District Public Prosecutor's Office, which manages legal proceedings in the region [2].
The former chairman had previously been the subject of a documentary indictment, a process where a person is formally charged based on written evidence without a public trial, before the final decision to forgo prosecution was reached this week [3].
“Former Suntory Holdings chairman Goshi Ninagawa will not be prosecuted”
The non-prosecution of a high-profile executive like Ninagawa suggests that the evidence may have been insufficient to secure a conviction or that the nature of the import did not meet the threshold for criminal intent. However, the initial documentary indictment underscores Japan's zero-tolerance approach toward cannabis-derived products, regardless of the individual's corporate status.
